ro

Înregistrează-te
Investițiile implică riscuri și nu sunt potrivite pentru toți investitorii.
Home・Listă Acțiuni・Laboratorios Farmaceuticos Rovi SA
Search

Laboratorios Farmaceuticos Rovi SA

Închisă

75.05 1.01

Cumpărare

Preț actualizat 16 sept. 2024, 15:29 UTC

CumpărăVinde

Rezumat

Modificarea prețului

24h

Curent

Minim

73.8

Maxim

76.85

Indicatori cheie

By Trading Economics

Venit

15M

Vânzări

-297M

151M

P/E

Medie Sector

24.61

EPS

0.292

Marjă de profit

9.896

EBITDA

26M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+34.33 upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-23M

4.1B

Deschiderea anterioară

74.04

Închiderea anterioară

75.05

Sentimentul știrilor

By Acuity

74%

26%

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

73.65 / 79.05 Suport & Rezistență

Laboratorios Farmaceuticos Rovi SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 sept. 2024, 01:45 UTC

Câștiguri

Preview -- Barron's

DJ

Citește

13 sept. 2024, 20:03 UTC

Top știri

Walgreens to Pay $106.8 Million Over Alleged Fraudulent Healthcare Billings

DJ

Citește

15 sept. 2024, 23:47 UTC

Market Talk

Gold Edges Higher Amid Mild Dollar Weakness -- Market Talk

DJ

Citește

15 sept. 2024, 23:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Citește

15 sept. 2024, 23:03 UTC

Market Talk

Australian Bond Traders Watchful as Fed Easing Nears -- Market Talk

DJ

Citește

15 sept. 2024, 16:52 UTC

Top știri

Boeing Machinist Strike Adds Cash Crunch to New CEO's Rescue Mission -- WSJ

DJ

Citește

15 sept. 2024, 09:30 UTC

Top știri

Interest Rates Are Too High. The Fed Should Cut by a Half Point. -- WSJ

DJ

Citește

15 sept. 2024, 07:00 UTC

Top știri

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

DJ

Citește

14 sept. 2024, 14:09 UTC

Top știri

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- Update 1 -- WSJ

DJ

Citește

14 sept. 2024, 13:25 UTC

Top știri

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- WSJ

DJ

Citește

14 sept. 2024, 09:30 UTC

Top știri

Why a Fed Rate Cut Won't Solve the Housing Wealth Gap -- WSJ

DJ

Citește

14 sept. 2024, 09:30 UTC

Top știri

Americans Are Falling Behind on Their Bills. Wall Street Is Alarmed. -- WSJ

DJ

Citește

14 sept. 2024, 03:00 UTC

Top știri

What Scared Ford's CEO in China -- WSJ

DJ

Citește

14 sept. 2024, 03:00 UTC

Top știri

What Scared Ford's CEO in China -- WSJ -2-

DJ

Citește

14 sept. 2024, 00:01 UTC

Top știri

Why 96% of Boeing's Machinists Voted to Go on Strike -- Update

DJ

Citește

13 sept. 2024, 21:14 UTC

Top știri

Why 96% of Boeing's Machinists Voted to Go on Strike -- WSJ

DJ

Citește

13 sept. 2024, 21:06 UTC

Top știri

Starliner Astronauts Say NASA Ran Short of Time to Test Boeing Craft -- WSJ

DJ

Citește

13 sept. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Citește

13 sept. 2024, 20:47 UTC

Market Talk

Saudi Arabia Credit Outlook Raised to Positive on Economic Investments -- Market Talk

DJ

Citește

13 sept. 2024, 20:44 UTC

Achiziții, Fuziuni, Preluări

Schlumberger Stock Was Once as Hot as Nvidia. Why It's a Buy. -- Barrons.com

DJ

Citește

13 sept. 2024, 20:41 UTC

Top știri

Berkshire Hathaway's Stock Is So Rich Even Berkshire Is Buying Less of It -- Update

DJ

Citește

13 sept. 2024, 20:31 UTC

Câștiguri

These Stocks Moved the Most Today: Adobe, Boeing, Trump Media, Oracle, Uber, RH, Moderna, Etsy, and More -- Barrons.com

DJ

Citește

13 sept. 2024, 20:13 UTC

Achiziții, Fuziuni, Preluări

BlackRock: Expects to Close Previously Announced Acquisition of Global Infrastructure Partners on Oct 1 >BLK

DJ

Citește

13 sept. 2024, 20:10 UTC

Achiziții, Fuziuni, Preluări

BlackRock Announces Expected Closing Date For Acquisition Of Global Infrastructure Partners >BLK

DJ

Citește

13 sept. 2024, 20:02 UTC

Achiziții, Fuziuni, Preluări

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

DJ

Citește

13 sept. 2024, 20:02 UTC

Achiziții, Fuziuni, Preluări

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

DJ

Citește

13 sept. 2024, 19:44 UTC

Market Talk

Treasury Yields Fall as Odds of 50bp Fed Cut Rise -- Market Talk

DJ

Citește

13 sept. 2024, 19:20 UTC

Market Talk

Crude-Oil Futures End Week With Small Gains -- Market Talk

DJ

Citește

13 sept. 2024, 19:09 UTC

Market Talk

U.S. Natural-Gas Futures Post Weekly Gain -- Market Talk

DJ

Citește

13 sept. 2024, 18:01 UTC

Market Talk

Gold Analysts Call For New Leg Of Rally -- Market Talk

DJ

Citește

Laboratorios Farmaceuticos Rovi SA Așteptări

Obiectiv de preț

By TipRanks

34.33% sus

Prognoză pe 12 luni

Medie 99 EUR  34.33%

Maxim 104 EUR

Minim 94 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruLaboratorios Farmaceuticos Rovi SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

2

Cumpărare

0

Păstrare

0

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Laboratorios Farmaceuticos Rovi SA - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

73.65 / 79.05Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Termen mediu

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Termen lung

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.